Folgen
Daniel Sargent
Daniel Sargent
Bestätigte E-Mail-Adresse bei mayo.edu
Titel
Zitiert von
Zitiert von
Jahr
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
EA Eisenhauer, P Therasse, J Bogaerts, LH Schwartz, D Sargent, R Ford, ...
European journal of cancer 45 (2), 228-247, 2009
277212009
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
A Grothey, E Van Cutsem, A Sobrero, S Siena, A Falcone, M Ychou, ...
The Lancet 381 (9863), 303-312, 2013
30222013
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
RM Goldberg, DJ Sargent, RF Morton, CS Fuchs, RK Ramanathan, ...
Journal of Clinical Oncology 22 (1), 23-30, 2004
29672004
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic, DJ Sargent, MJ Moore, SN Thibodeau, AJ French, ...
New England Journal of Medicine 349 (3), 247-257, 2003
26752003
Guidelines 2000 for colon and rectal cancer surgery
H Nelson, N Petrelli, A Carlin, J Couture, J Fleshman, J Guillem, ...
Journal of the National Cancer Institute 93 (8), 583-596, 2001
18192001
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ...
The Lancet 391 (10135), 2128-2139, 2018
17832018
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
DJ Sargent, S Marsoni, G Monges, SN Thibodeau, R Labianca, ...
Journal of clinical oncology 28 (20), 3219, 2010
17642010
Prognostic factors in colorectal cancer: College of American Pathologists consensus statement 1999
CC Compton, LP Fielding, LJ Burgart, B Conley, HS Cooper, SR Hamilton, ...
Archives of pathology & laboratory medicine 124 (7), 979-994, 2000
16892000
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy
S Kopetz, GJ Chang, MJ Overman, C Eng, DJ Sargent, DW Larson, ...
Journal of clinical oncology 27 (22), 3677, 2009
15022009
Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial
J Fleshman, DJ Sargent, E Green, M Anvari, SJ Stryker, RW Beart Jr, ...
Annals of surgery 246 (4), 655-664, 2007
14282007
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
A Grothey, D Sargent, RM Goldberg, HJ Schmoll
Journal of Clinical Oncology 22 (7), 1209-1214, 2004
13372004
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
S Gill, CL Loprinzi, DJ Sargent, SD Thomé, SR Alberts, DG Haller, ...
Journal of clinical oncology 22 (10), 1797-1806, 2004
13122004
Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial
J Fleshman, M Branda, DJ Sargent, AM Boller, V George, M Abbas, ...
Jama 314 (13), 1346-1355, 2015
12112015
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients
DJ Sargent, RM Goldberg, SD Jacobson, JS Macdonald, R Labianca, ...
New England Journal of Medicine 345 (15), 1091-1097, 2001
11632001
Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial
JC Weeks, H Nelson, S Gelber, D Sargent, G Schroeder, ...
Jama 287 (3), 321-328, 2002
9832002
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors
NM Lindor, LJ Burgart, O Leontovich, RM Goldberg, JM Cunningham, ...
Journal of clinical oncology 20 (4), 1043-1048, 2002
9682002
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.
X Paoletti, K Oba, T Burzykowski, S Michiels, Y Ohashi, JP Pignon, ...
Jama 303 (17), 1729-1737, 2010
9242010
Duration of adjuvant chemotherapy for stage III colon cancer
A Grothey, AF Sobrero, AF Shields, T Yoshino, J Paul, J Taieb, ...
New England Journal of Medicine 378 (13), 1177-1188, 2018
8982018
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)
A Grothey, MM Sugrue, DM Purdie, W Dong, D Sargent, E Hedrick, ...
J Clin Oncol 26 (33), 5326-5334, 2008
8902008
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials
DJ Sargent, HS Wieand, DG Haller, R Gray, JK Benedetti, M Buyse, ...
Journal of Clinical Oncology 23 (34), 8664-8670, 2005
7782005
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20